Sanofi makes bid for Genzyme  
French drug maker Sanofi-Aventis SA has offered to buy U.S. biotechnology company Genzyme Corp. for $18.5 billion, or $69 per share.



Read 110
Published 2010-08-29
Tracked 2010-08-29
Channel Finance
Language English
Media
Country United States